Age-related increase in anaphylaxis severity is associated with enhanced sensitivity to allergic mediatorsTo the Editor,Anaphylactic shock is the most severe outcome of an immunoglobulin E (IgE)-mediated allergy. This potentially life-threatening reaction with multi-organ involvement is characterized by a rapid hypersensitivity response to allergen exposure. Despite the well-documented general decline in immune cell function associated with aging, referred to as immunosenescence (1), older adults often experience more severe allergic reactions as compared to younger patients (2,3). Given the rising incidence of severe anaphylaxis (4) in conjunction with the rapidly growing elderly population (5), we sought to investigate the underlying mechanisms contributing to this age-related increase in allergy severity.First, we investigated whether the age-related increase in anaphylaxis severity that has been observed in humans is reproducible in mice. For this purpose, we passively sensitized young and aged C57BL/6 wild type (WT) mice intravenously with 2,4,6-trinitrophenyl (TNP)-specific IgE (clone: MEB-38), followed by intraperitoneal challenge with TNP-ovalbumin conjugate (TNP-OVA) on the next day (Figure 1A). Indeed, aged mice exhibited significantly stronger anaphylactic responses, evidenced by greater loss in body temperature (Figure 1B) and a larger area under the hypothermia curve (AUC) (Figure 1C). To our surprise, serum levels of allergic effector cell-related mediators including histamine and mMCP-1 showed no significant differences between age groups (Figure 1D and E).To further confirm these findings, we used humanized FcεRIα (huFcεRIα) mice sensitized with equal amounts of 4-hydroxy-3-iodo-5-nitrophenylacetyl (NIP)-specific human IgE (clone: JW8) followed by intraperitoneal challenge with NIP-bovine serum albumin conjugate (NIP-BSA) on the next day (Figure 1F). The pattern of exaggerated anaphylaxis in aged mice was consistent, with increased body core temperature loss and AUC values (Figure 1G and H). Further analysis of allergic effector cell mediator levels (histamine and mMCP-1) again showed no age-related differences (Figure 1I and J).To explore potential contributors to increased anaphylaxis severity in aged mice, we additionally quantified basophil cell numbers and the amount of NIP-BSA-specific IgE on blood basophils before antigen challenge. Interestingly, aged mice showed neither increased blood basophil counts nor higher IgE levels on these cells (Figure 1K and L). In contrast, the amount of NIP-BSA-specific IgE on blood basophils was significantly lower in aged compared to young mice (Figure 1L), whileex vivo sensitization with exogenous IgE exhibited comparable IgE loading on blood basophils from young and aged mice, indicating that the reduced in vivo IgE binding was not due to differences in available high-affinity IgE receptor levels on these cells (Figure 1M).To further evaluate potential age-related changes in allergic effector cell behavior, we cultured bone marrow-derived mast cells (BMMCs) from young and aged WT and huFcεRIα mice and assessed their degranulation capacity in vitro . Aged BMMCs sensitized with JW8-IgE, Sus11-IgE or MEB38-IgE and challenged either in an antigen-dependent (NIP-BSA/TNP-OVA) or -independent (anti-IgE antibody Le27) way unexpectedly showed reduced activation levels as compared to young BMMCs as measured by surface levels of the degranulation marker CD107a (Figure 2A and B). Overall, these data strongly indicate that neither allergic effector cell expansion or function nor increased IgE-binding capacity appears to drive enhanced anaphylaxis severity in aged mice.Finally, to test the hypothesis whether aging might lead to an increased sensitivity to allergic mediators, we bypassed allergic effector cell activation and directly administered a fixed amount of exogenous histamine to young and aged WT mice (Figure 2C). Strikingly, aged mice showed significantly stronger anaphylactic responses (Figure 2D and E) at equal serum histamine levels (Figure 2F) indicating increased physiological sensitivity to allergic effector cell-derived mediators.In summary, our findings reveal that age-related increase in anaphylaxis severity is independent of altered effector cell activity or mediator release but is associated with an enhanced physiological responsiveness to allergic mediators such as histamine.